ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer

References

• JemalASiegelRWardEHaoYXuJThunMJCancer statistics, 2009CA Cancer J Clin200959422524919474385
   PubMed Web of Science ®Google Scholar
• SeiwertTYSalamaJKVokesEEThe concurrent chemoradiation paradigm – general principlesNat Clin Pract Oncol2007428610017259930
   PubMedGoogle Scholar
• MurdochDStandard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based reviewCurr Opin Oncol200719321622117414639
   PubMed Web of Science ®Google Scholar
• SeiwertTYSalamaJKVokesEEThe chemoradiation paradigm in head and neck cancerNat Clin Pract Oncol20074315617117327856
   PubMedGoogle Scholar
• O’DriscollMJeggoPAThe role of double-strand break repair – insights from human geneticsNat Rev Genet200671455416369571
   PubMed Web of Science ®Google Scholar
• PetermannEHelledayTPathways of mammalian replication fork restartNat Rev Mol Cell Biol2010111068368720842177
   PubMed Web of Science ®Google Scholar
• NiedernhoferLJLalaiASHoeijmakersJHFanconi anemia (cross) linked to DNA repairCell200512371191119816377561
   PubMed Web of Science ®Google Scholar
• KennedyRDD’AndreaADDNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromesJ Clin Oncol200624233799380816896009
   PubMed Web of Science ®Google Scholar
• NiedernhoferLJGarinisGARaamsAA new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axisNature200644471221038104317183314
   PubMed Web of Science ®Google Scholar
• AhmadARobinsonARDuensingAERCC1-XPF endonuclease facilitates DNA double-strand break repairMol Cell Biol200828165082509218541667
   PubMed Web of Science ®Google Scholar
• BhagwatNOlsenALWangATXPF-ERCC1 participates in the fanconi anemia pathway of cross-link repairMol Cell Biol200929246427643719805513
   PubMed Web of Science ®Google Scholar
• JaspersNGRaamsASilengoMCFirst reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failureAm J Hum Genet200780345746617273966
   PubMed Web of Science ®Google Scholar
• ZwellingLAAndersonTKohnKWDNA-protein and DNA inter-strand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicityCancer Res1979392 Pt 1365369570092
   PubMed Web of Science ®Google Scholar
• McHughPJSpanswickVJHartleyJARepair of DNA interstrand crosslinks: molecular mechanisms and clinical relevanceLancet Oncol20012848349011905724
   PubMed Web of Science ®Google Scholar
• MartinLPHamiltonTCSchilderRJPlatinum resistance: the role of DNA repair pathwaysClin Cancer Res20081451291129518316546
   PubMed Web of Science ®Google Scholar
• HoeijmakersJHDNA damage, aging, and cancerN Engl J Med2009361151475148519812404
   PubMed Web of Science ®Google Scholar
• LadigesWCMouse models of XRCC1 DNA repair polymorphisms and cancerOncogene200625111612161916550161
   PubMed Web of Science ®Google Scholar
• AlmeidaKHSobolRWA unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modificationDNA Repair (Amst)20076669571117337257
   PubMed Web of Science ®Google Scholar
• CaldecottKWXRCC1 and DNA strand break repairDNA Repair (Amst)20032995596912967653
   PubMed Web of Science ®Google Scholar
• LinYHatemJWangJQuinnAHicksDTangPTissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breastBiotech Histochem2010812 Epub ahead of print.
   Web of Science ®Google Scholar
• TamakiKSasanoHIshidaTComparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patientsCancer Sci201010192074207920557310
   PubMed Web of Science ®Google Scholar
• TailladeLPenault-LlorcaFBouletTImmunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancerAnn Oncol20071861043105017355950
   PubMed Web of Science ®Google Scholar
• BabicALoftinIRStanislawSThe impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in situ hybridization and fluorescent in situ hybridization assaysMethods201052428730020807574
   PubMed Web of Science ®Google Scholar
• McShaneLMAltmanDGSauerbreiWTaubeSEGionMClarkGMReporting recommendations for tumor marker prognostic studies (REMARK)J Natl Cancer Inst200597161180118416106022
   PubMed Web of Science ®Google Scholar
• NiedernhoferLJBhagwatNWoodRDERCC1 and non-small-cell lung cancerN Engl J Med20073562425382540 author reply2540253117568038
   PubMed Web of Science ®Google Scholar
• BrittenRALiuDTessierAHutchisonMJMurrayDERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cellsInt J Cancer200089545345711008208
   PubMed Web of Science ®Google Scholar
• ZhengZChenTLiXHauraESharmaABeplerGDNA synthesis and repair genes RRM1 and ERCC1 in lung cancerN Engl J Med2007356880080817314339
   PubMed Web of Science ®Google Scholar
• McGurkCJCummingsMKoberleBHartleyJAOliverRTMastersJRRegulation of DNA repair gene expression in human cancer cell linesJ Cell Biochem20069751121113616315315
   PubMed Web of Science ®Google Scholar
• KimSMisraASNP genotyping: technologies and biomedical applicationsAnnu Rev Biomed Eng2007928932017391067
   PubMed Web of Science ®Google Scholar
• SchneiderJClassenVPhilippMHelmigSRapid analysis of XRCC1 polymorphisms using real-time polymerase chain reactionMol Cell Probes2006203–425926216542819
   PubMed Web of Science ®Google Scholar
• FountzilasGKalogera-FountzilaALambakiSMMP9 but not EGFR, MET, ERCC1, P16, and P-53 is associated with response to concomitant radiotherapy, cetuximab, and weekly cisplatin in patients with locally advanced head and neck cancerJ Oncol2009200930590820066159
   PubMedGoogle Scholar
• MatulloGDunningAMGuarreraSDNA repair polymorphisms and cancer risk in non-smokers in a cohort studyCarcinogenesis2006275997100716308313
   PubMed Web of Science ®Google Scholar
• FerteCAndreFSoriaJCMolecular circuits of solid tumors: prognostic and predictive tools for bedside useNat Rev Clin Oncol20107736738020551944
   PubMed Web of Science ®Google Scholar
• SrivastavaSGrayJWReidBJGradOGreenwoodAHawkETTranslational Research Working Group developmental pathway for biospecimen-based assessment modalitiesClin Cancer Res200814185672567718794074
   PubMed Web of Science ®Google Scholar
• FordBNRuttanCCKyleVLBrackleyMEGlickmanBWIdentification of single nucleotide polymorphisms in human DNA repair genesCarcinogenesis200021111977198111062157
   PubMed Web of Science ®Google Scholar
• YuJJMuCLeeKBA nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissuesMutat Res19973821–213209360634
   PubMed Web of Science ®Google Scholar
• YangMKimWHChoiYEffects of ERCC1 expression in peripheral blood on the risk of head and neck cancerEur J Cancer Prev200615326927316679872
   PubMed Web of Science ®Google Scholar
• OkudaKSasakiHHikosakaYExcision repair cross complementation group 1 polymorphisms predict overall survival after platinum-based chemotherapy for completely resected non-small-cell lung cancerJ Surg Res2009926 Epub ahead of print.
   Web of Science ®Google Scholar
• ZhouWLiuGParkSGene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancerCancer Epidemiol Biomarkers Prev200514249149615734977
   PubMed Web of Science ®Google Scholar
• YinJVogelUGuoLMaYWangHLack of association between DNA repair gene ERCC1 polymorphism and risk of lung cancer in a Chinese populationCancer Genet Cytogenet20061641667016364765
   PubMedGoogle Scholar
• HungRJChristianiDCRischAInternational Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathwaysCancer Epidemiol Biomarkers Prev200817113081308918990748
   PubMed Web of Science ®Google Scholar
• YuDZhangXLiuJCharacterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosisClin Cancer Res20081492878288618451256
   PubMed Web of Science ®Google Scholar
• DengQShengLSuDGenetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast ChinaMed Oncol2010331 Epub ahead of print.
   Web of Science ®Google Scholar
• ZienolddinySCampaDLindHPolymorphisms of DNA repair genes and risk of non-small cell lung cancerCarcinogenesis200627356056716195237
   PubMed Web of Science ®Google Scholar
• MaHXuLYuanJTagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese populationPharmacogenet Genomics200717641742317502833
   PubMed Web of Science ®Google Scholar
• ShenMBerndtSIRothmanNPolymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, ChinaInt J Cancer2005116576877315849729
   PubMed Web of Science ®Google Scholar
• JonesNRSprattTEBergASMuscatJELazarusPGallagherCJAssociation studies of excision repair cross-complementation group 1 (ERCC1) haplotypes with lung and head and neck cancer risk in a Caucasian populationCancer Epidemiol201135217518120863778
   PubMed Web of Science ®Google Scholar
• LiYGuSWuQNo association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysisEur J Hum Genet200715996797317522621
   PubMed Web of Science ®Google Scholar
• KiyoharaCYoshimasuKGenetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysisInt J Med Sci200742597117299578
   PubMedGoogle Scholar
• VineisPManuguerraMKavvouraFKA field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibilityJ Natl Cancer Inst20091011243619116388
   PubMedGoogle Scholar
• ChengLSpitzMRHongWKWeiQReduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysisCarcinogenesis20002181527153010910954
   PubMed Web of Science ®Google Scholar
• SugimuraTKumimotoHTohnaiIGene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphismsJ Oral Pathol Med2006351111816393248
   PubMed Web of Science ®Google Scholar
• AbbasiRRamrothHBecherHDietzASchmezerPPopandaOLaryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genesInt J Cancer200912561431143919444904
   PubMed Web of Science ®Google Scholar
• CanovaCHashibeMSimonatoLGenetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE projectCancer Res20096972956296519339270
   PubMed Web of Science ®Google Scholar
• SturgisEMDahlstromKRSpitzMRWeiQDNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neckArch Otolaryngol Head Neck Surg200212891084108812220217
   PubMedGoogle Scholar
• ChengLSturgisEMEicherSASpitzMRWeiQExpression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neckCancer200294239339711900225
   PubMed Web of Science ®Google Scholar
• KalikakiAKanakiMVassalouHDNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancerClin Lung Cancer200910211812319362955
   PubMed Web of Science ®Google Scholar
• GandaraDRKawaguchiTCrowleyJJapanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomicsJ Clin Oncol200927213540354619470925
   PubMed Web of Science ®Google Scholar
• SukRGurubhagavatulaSParkSPolymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patientsClin Cancer Res20051141534153815746057
   PubMed Web of Science ®Google Scholar
• TakenakaTYoshinoIKousoHCombined evaluation of Rad51 and ERCC1 expressions for sensitivity to platinum agents in non-small cell lung cancerInt J Cancer2007121489590017417781
   PubMed Web of Science ®Google Scholar
• TibaldiCGiovannettiEVasileECorrelation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patientsClin Cancer Res20081461797180318347182
   PubMed Web of Science ®Google Scholar
• VinolasNProvencioMReguartNSingle nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbineLung Cancer201171219119820627363
   PubMed Web of Science ®Google Scholar
• ZhouWGurubhagavatulaSLiuGExcision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapyClin Cancer Res200410154939494315297394
   PubMed Web of Science ®Google Scholar
• ParkSYHongYCKimJHEffect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patientsMed Oncol200623448949817303907
   PubMed Web of Science ®Google Scholar
• RyuJSHongYCHanHSAssociation between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapyLung Cancer200444331131615140544
   PubMed Web of Science ®Google Scholar
• SuDMaSLiuPGenetic polymorphisms and treatment response in advanced non-small cell lung cancerLung Cancer200756228128817222938
   PubMed Web of Science ®Google Scholar
• YinZZhouBHeQAssociation between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinomaBMC Cancer2009943920003463
   PubMed Web of Science ®Google Scholar
• IslaDSarriesCRosellRSingle nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancerAnn Oncol20041581194120315277258
   PubMed Web of Science ®Google Scholar
• ZhouCRenSZhouSPredictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patientsJpn J Clin Oncol2010401095496020462983
   PubMed Web of Science ®Google Scholar
• LiFSunXSunNAssociation between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancerAm J Clin Oncol201033548949420351547
   PubMed Web of Science ®Google Scholar
• De las PenasRSanchez-RoncoMAlberolaVPolymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patientsAnn Oncol200617466867516407418
   PubMed Web of Science ®Google Scholar
• WeiSZZhanPShiMQPredictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysisMed Oncol201128131532120143185
   PubMed Web of Science ®Google Scholar
• TakenakaTYanoTKiyoharaCEffects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patientsLung Cancer201067110110719361884
   PubMed Web of Science ®Google Scholar
• Quintela-FandinoMHittRMedinaPPDNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapyJ Clin Oncol200624264333433916896002
   PubMed Web of Science ®Google Scholar
• GrauJJCaballeroMCampayoMGene single nucleotide polymorphism accumulation improves survival in advanced head and neck cancer patients treated with weekly paclitaxelLaryngoscope200911981484149019504558
   PubMed Web of Science ®Google Scholar
• CarlesJMonzoMAmatMSingle-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancerInt J Radiat Oncol Biol Phys20066641022103016979838
   PubMed Web of Science ®Google Scholar
• WangXZhaoJYangLPositive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancerMed Oncol201027248449019488864
   PubMed Web of Science ®Google Scholar
• VilmarASantoni-RugiuESorensenJBERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trialEur J Cancer20104691554156220395129
   PubMed Web of Science ®Google Scholar
• ReynoldsCObasajuCSchellMJRandomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancerJ Clin Oncol200927345808581519884554
   PubMed Web of Science ®Google Scholar
• OtaSIshiiGGotoKImmunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapyLung Cancer20096419810418823676
   PubMed Web of Science ®Google Scholar
• OlaussenKADunantAFouretPDNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapyN Engl J Med20063551098399116957145
   PubMed Web of Science ®Google Scholar
• LeeHWChoiYWHanJHExpression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapyLung Cancer200965337738219150580
   PubMed Web of Science ®Google Scholar
• FujiiTToyookaSIchimuraKERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancerLung Cancer200859337738417905465
   PubMed Web of Science ®Google Scholar
• AzumaKKomoharaYSasadaTExcision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapyCancer Sci20079891336134317640298
   PubMed Web of Science ®Google Scholar
• AzumaKSasadaTKawaharaAExpression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiationCancer Chemother Pharmacol200964356557319123003
   PubMed Web of Science ®Google Scholar
• HolmBMellemgaardASkovTSkovBGDifferent impact of excision repair cross-complementation group 1 on survival in male and female patients with inoperable non-small-cell lung cancer treated with carboplatin and gemcitabineJ Clin Oncol200927264254425919667277
   PubMed Web of Science ®Google Scholar
• LeeKHMinHSHanSWERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancerLung Cancer200860340140718036700
   PubMed Web of Science ®Google Scholar
• KangCHJangBGKimDWThe prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resectionLung Cancer201068347848319683826
   PubMed Web of Science ®Google Scholar
• KohYJangBHanSWExpression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancerJ Thorac Oncol20105332032520087230
   PubMed Web of Science ®Google Scholar
• PlanchardDDomontJTaranchonEThe NER proteins are differentially expressed in ever smokers and in never smokers with lung adenocarcinomaAnn Oncol20092071257126319297315
   PubMed Web of Science ®Google Scholar
• OkudaKSasakiHDumontetCExpression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancerLung Cancer200862110511218395930
   PubMed Web of Science ®Google Scholar
• VilmarACSantoni-RugiuESorensenJBERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trialAnn Oncol20102191817182420332140
   PubMed Web of Science ®Google Scholar
• ChenSZhangJWangRLuoXChenHThe platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysisLung Cancer2010701637020541281
   PubMed Web of Science ®Google Scholar
• DollCMPrystajeckyMEliasziwMLow ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation aloneRadiother Oncol201097235235920934765
   PubMed Web of Science ®Google Scholar
• FountzilasGBamiasAKalogera-FountzilaAInduction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neckAnticancer Res200929252953819331199
   PubMed Web of Science ®Google Scholar
• KohYKimTMJeonYKClass III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinomaAnn Oncol20092081414141919468031
   PubMed Web of Science ®Google Scholar
• Handra-LucaAHernandezJMountziosGExcision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinomaClin Cancer Res200713133855385917606717
   PubMed Web of Science ®Google Scholar
• JunHJAhnMJKimHSERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiationBr J Cancer200899116717218594541
   PubMed Web of Science ®Google Scholar
• ShimizuJHorioYOsadaHmRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cis-platin, carboplatin and gemcitabine in human lung cancer cell linesRespirology200813451051718494946
   PubMed Web of Science ®Google Scholar
• RosellRFelipETaronMGene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgeryClin Cancer Res20041012 Pt 24215s4219s15217961
   PubMed Web of Science ®Google Scholar
• SimonGRSharmaSCantorASmithPBeplerGERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancerChest2005127397898315764785
   PubMed Web of Science ®Google Scholar
• CeppiPVolanteMNovelloSERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabineAnn Oncol200617121818182516980606
   PubMed Web of Science ®Google Scholar
• LordRVBrabenderJGandaraDLow ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancerClin Cancer Res2002872286229112114432
   PubMed Web of Science ®Google Scholar
• CeppiPLongoMVolanteMExcision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective studyJ Thorac Oncol20083658358918520795
   PubMed Web of Science ®Google Scholar
• CoboMIslaDMassutiBCustomizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancerJ Clin Oncol200725192747275417602080
   PubMed Web of Science ®Google Scholar
• BootonRWardTAshcroftLMorrisJHeighwayJThatcherNERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancerJ Thorac Oncol200721090290617909351
   PubMed Web of Science ®Google Scholar
• SimonGSharmaALiXFeasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancerJ Clin Oncol200725192741274617602079
   PubMed Web of Science ®Google Scholar
• SuCZhouSZhangLERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancerMed Oncol2010514 Epub ahead of print.
   Web of Science ®Google Scholar
• RenSZhouSZhangLHigh-level mRNA of excision repair cross-complementation group 1 gene is associated with poor outcome of platinum-based doublet chemotherapy of advanced nonsmall cell lung cancer patientsCancer Invest201028101078108320504223
   PubMed Web of Science ®Google Scholar
• BeplerGKusmartsevaISharmaSRRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancerJ Clin Oncol200624294731473716966686
   PubMed Web of Science ®Google Scholar
• Pers comm; 13th Annual Midwest DNA Repair MeetingToledo, Ohio, USABaghwatNehaNiedernhoferLaura J2011
   Google Scholar
• SchneiderJClassenVBerngesUPhilippMXRCC1 polymorphism and lung cancer risk in relation to tobacco smokingInt J Mol Med200516470971616142409
   PubMed Web of Science ®Google Scholar
• HaoBMiaoXLiYA novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancerOncogene200625253613362016652158
   PubMed Web of Science ®Google Scholar
• HuZMaHLuDA promoter polymorphism (−77T > C) of DNA repair gene XRCC1 is associated with risk of lung cancer in relation to tobacco smokingPharmacogenet Genomics200515745746315970793
   PubMed Web of Science ®Google Scholar
• HsiehWCChengYWLinCJChouMCChenCYLeeHPrognostic significance of X-ray cross-complementing group 1 T-77C polymorphism in resected non-small cell lung cancerJpn J Clin Oncol2009392818519052039
   PubMed Web of Science ®Google Scholar
• De RuyckKSzaumkesselMDe RudderIPolymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer riskMutat Res2007631210111017531525
   PubMed Web of Science ®Google Scholar
• LadigesWWileyJMacAuleyAPolymorphisms in the DNA repair gene XRCC1 and age-related diseaseMech Ageing Dev20031241273212618003
   PubMed Web of Science ®Google Scholar
• ChengJLengSLiHSuboptimal DNA repair capacity predisposes coke-oven workers to accumulate more chromosomal damages in peripheral lymphocytesCancer Epidemiol Biomarkers Prev200918398799319240242
   PubMed Web of Science ®Google Scholar
• Abdel-RahmanSZEl-ZeinRAThe 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNKCancer Lett20001591637110974407
   PubMed Web of Science ®Google Scholar
• ReltonCLDanielCPFisherAChaseDSBurnJTawnEJPolymorphisms of the DNA repair gene XRCC1 and the frequency of somatic mutations at the glycophorin A locus in newbornsMutat Res20025021–2616811996973
   PubMed Web of Science ®Google Scholar
• LunnRMLangloisRGHsiehLLThompsonCLBellDAXRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequencyCancer Res199959112557256110363972
   PubMed Web of Science ®Google Scholar
• MisraRRRatnasingheDTangreaJAPolymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in FinlandCancer Lett2003191217117812618330
   PubMed Web of Science ®Google Scholar
• YinJVogelUMaYQiRWangHAssociation of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese womenCancer Genet Cytogenet20091881263119061777
   PubMedGoogle Scholar
• ButkiewiczDRusinMEnewoldLShieldsPGChorazyMHarrisCCGenetic polymorphisms in DNA repair genes and risk of lung cancerCarcinogenesis200122459359711285194
   PubMed Web of Science ®Google Scholar
• ChenSTangDXueKDNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese populationCarcinogenesis20022381321132512151350
   PubMed Web of Science ®Google Scholar
• ImprotaGSgambatoABianchinoGPolymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian populationAnticancer Res2008285B2941294619031937
   PubMed Web of Science ®Google Scholar
• HungRJBrennanPCanzianFLarge-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter studyJ Natl Cancer Inst200597856757615840879
   PubMedGoogle Scholar
• RatnasingheDYaoSXTangreaJAPolymorphisms of the DNA repair gene XRCC1 and lung cancer riskCancer Epidemiol Biomarkers Prev200110211912311219768
   PubMed Web of Science ®Google Scholar
• ShenMBerndtSIRothmanNPolymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, ChinaAnticancer Res2005251B53754215816625
   PubMed Web of Science ®Google Scholar
• TanakaYManiwaYBermudezVPNonsynonymous single nucleotide polymorphisms in DNA damage repair pathways and lung cancer riskCancer2010116489690220052722
   PubMed Web of Science ®Google Scholar
• YinJVogelUMaYQiRSunZWangHThe DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese populationLung Cancer200756215316017316890
   PubMed Web of Science ®Google Scholar
• David-BeabesGLLondonSJGenetic polymorphism of XRCC1 and lung cancer risk among African-Americans and CaucasiansLung Cancer200134333333911714530
   PubMed Web of Science ®Google Scholar
• PachouriSSSobtiRCKaurPSinghJContrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in the north-Indian populationDNA Cell Biol200726318619117417947
   PubMed Web of Science ®Google Scholar
• VogelUNexoBAWallinHOvervadKTjonnelandARaaschou-NielsenONo association between base excision repair gene polymorphisms and risk of lung cancerBiochem Genet20044211–1245346015587988
   PubMed Web of Science ®Google Scholar
• ItoHMatsuoKHamajimaNGene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer riskCarcinogenesis20042581395140115044328
   PubMed Web of Science ®Google Scholar
• Lopez-CimaMFGonzalez-ArriagaPGarcia-CastroLPolymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern SpainBMC Cancer2007716217705814
   PubMed Web of Science ®Google Scholar
• PopandaOSchattenbergTPhongCTSpecific combinations of DNA repair gene variants and increased risk for non-small cell lung cancerCarcinogenesis200425122433244115333465
   PubMed Web of Science ®Google Scholar
• RykCKumarRThirumaranRKHouSMPolymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokersLung Cancer200654328529217034901
   PubMed Web of Science ®Google Scholar
• ZhangXMiaoXLiangGPolymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancerCancer Res200565372272615705867
   PubMed Web of Science ®Google Scholar
• ParkJYLeeSYJeonHSPolymorphism of the DNA repair gene XRCC1 and risk of primary lung cancerCancer Epidemiol Biomarkers Prev2002111232711815397
   PubMed Web of Science ®Google Scholar
• ZhouWLiuGMillerDPPolymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer riskCancer Epidemiol Biomarkers Prev200312435936512692111
   PubMed Web of Science ®Google Scholar
• SreejaLSyamalaVSSyamalaVPrognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from IndiaJ Cancer Res Clin Oncol2008134664565217952468
   PubMed Web of Science ®Google Scholar
• DivineKKGillilandFDCrowellREThe XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lungMutat Res2001461427327811104903
   PubMed Web of Science ®Google Scholar
• ApplebaumKMMcCleanMDNelsonHHMarsitCJChristensenBCKelseyKTSmoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinomaInt J Cancer2009124112690269619230024
   PubMed Web of Science ®Google Scholar
• CsejteiATiboldAKoltaiKAssociation between XRCC1 polymorphisms and head and neck cancer in a Hungarian populationAnticancer Res200929104169417319846968
   PubMed Web of Science ®Google Scholar
• HarthVSchaferMAbelJHead and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repairJ Toxicol Environ Health A20087113–1488789718569591
   PubMed Web of Science ®Google Scholar
• ShenHSturgisEMKhanSGAn intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control studyCancer Res20016183321332511309287
   PubMed Web of Science ®Google Scholar
• OlshanAFWatsonMAWeisslerMCBellDAXRCC1 polymorphisms and head and neck cancerCancer Lett2002178218118611867203
   PubMed Web of Science ®Google Scholar
• KowalskiMPrzybylowskaKRusinPGenetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neckJ Exp Clin Cancer Res2009283719284666
   PubMed Web of Science ®Google Scholar
• TaeKLeeHSParkBJAssociation of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean populationInt J Cancer2004111580580815252855
   PubMed Web of Science ®Google Scholar
• SturgisEMCastilloEJLiLPolymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neckCarcinogenesis199920112125212910545415
   PubMed Web of Science ®Google Scholar
• ChoEYHildesheimAChenCJNasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1Cancer Epidemiol Biomarkers Prev200312101100110414578150
   PubMed Web of Science ®Google Scholar
• GalTJHuangWYChenCHayesRBSchwartzSMDNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patientsLaryngoscope2005115122221223116369171
   PubMed Web of Science ®Google Scholar
• HuangWYOlshanAFSchwartzSMSelected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysisCancer Epidemiol Biomarkers Prev20051471747175316030112
   PubMed Web of Science ®Google Scholar
• PettyWJKnightSNMosleyLA pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancerJ Thorac Oncol20072319720217410042
   PubMed Web of Science ®Google Scholar
• WangZXuBLinDXRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese populationLung Cancer20086219910418400332
   PubMed Web of Science ®Google Scholar
• YuanPLiuLWuCNo association between XRCC1 polymorphis and survival in non-small-cell lung cancer patients treated with platinum-based chemotherapyCancer Biol Ther2010109
   Web of Science ®Google Scholar
• YoonSMHongYCParkHJThe polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapyInt J Radiat Oncol Biol Phys200563388589116199318
   PubMed Web of Science ®Google Scholar
• SunXLiFSunNPolymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patientsLung Cancer200965223023619157633
   PubMed Web of Science ®Google Scholar
• GiachinoDFGhioPRegazzoniSProspective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancerClin Cancer Res200713102876288117504986
   PubMed Web of Science ®Google Scholar
• GurubhagavatulaSLiuGParkSXPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapyJ Clin Oncol200422132594260115173214
   PubMed Web of Science ®Google Scholar
• GeislerSAOlshanAFCaiJWeisslerMSmithJBellDGlutathione S-transferase polymorphisms and survival from head and neck cancerHead Neck200527323224215668931
   PubMed Web of Science ®Google Scholar
• WeaverDACrawfordELWarnerKAElkhairiFKhuderSAWilleyJCABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell linesMol Cancer2005411815882455
   PubMed Web of Science ®Google Scholar
• KangCHJangBGKimDWDifferences in the expression profiles of excision repair crosscomplementation group 1, x-ray repair crosscomplementation group 1, and betaIII-tubulin between primary non-small cell lung cancer and metastatic lymph nodes and the significance in mid-term survivalJ Thorac Oncol20094111307131219745766
   PubMed Web of Science ®Google Scholar
• NixPGreenmanJStaffordNCawkwellLExpression of XRCC1 and ERCC1 proteins in radioresistant and radiosensitive laryngeal cancerCancer Therapy200424753
   Google Scholar
• CampioniMAmbrogiVPompeoEIdentification of genes down-regulated during lung cancer progression: a cDNA array studyJ Exp Clin Cancer Res2008273818793406
   PubMed Web of Science ®Google Scholar
• JonesNRSprattTEBergASMuscatJELazarusPGallagherCJAssociation studies of excision repair cross-complementation group 1 (ERCC1) haplotypes with lung and head and neck cancer risk in a Caucasian populationCancer Epidemiol20103521758120863778
   PubMed Web of Science ®Google Scholar
• VarzimGMonteiroESilvaRAFernandesJLopesCCYP1A1 and XRCC1 gene polymorphisms in SCC of the larynxEur J Cancer Prev200312649549914639127
   PubMed Web of Science ®Google Scholar